Article 1 to 1 out of 1 concerning MacoPharma S.A.
ProMetic, American Red Cross and Macopharma to Market the First Product for the Selective Adsorbtion of Prions out from Blood(03 Aug 2004) Initial European roll out planned for 2005 - Strategic alliance to include development of filters for viruses - MacoPharma to market and distribute the products Pathogen Removal and Diagnostic Technologies Inc. (PRDT), the joint venture company of ProMetic Life Sciences Inc. and the American Red Cross, announced today the formation of a strategic alliance with MacoPharma, one of the largest distributors of ...
Top
